Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.7 USD | -0.07% | +6.58% | +20.85% |
03:02pm | Merck: new indication approved for Keytruda in Europe | CF |
01:45pm | Merck Says Keytruda Plus Chemotherapy as Neoadjuvant Treatment Receives Approval From European Commission | MT |
- Stock
- Equities
- Stock Merck & Co., Inc. - Nyse
- News Merck & Co., Inc.